This study is completed in the United States, in Colombia, in India, .... It is testing lurasidone for schizophrenia.
SchizophreniaDrugFrom 18 Years to 75 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Lurasidone may be useful for adults experiencing schizophrenia.
What would participation involve?
Participants may receive Lurasidone, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Colombia, in India, and in Lithuania.
Who is it mainly for?
This study appears to be mainly for adults with schizophrenia.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateJanuary 2008
Recruitment status
Completed
Enrollment listed in the registry
478
Sponsor
Sumitomo Pharma America, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Colombia, India, ...
Age range
From 18 Years to 75 Years
Official registry ID
NCT00615433
Official title
A Phase 3 Randomized, Placebo-and Active Comparator Controlled, Clinical Trial to Study the Safety and Efficacy of Two Doses of Lurasidone HCl in Acutely Psychotic Patients With Schizophrenia.
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT00615433. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Colombia · 5 sites
Instituto Colombiano del Sistema Nervioso Clinica Montserrat
Cundinamarca, Bogota D.C.
Site status: Not listed — confirm with the team
CIPNA Centro de Investigaciones y Proyectos en Neurociencias
Barranquilla
Site status: Not listed — confirm with the team
Centro de Investigacion y Atencion para la Salud Mental
Bogotá
Site status: Not listed — confirm with the team
Centro de Investigaciones del Sistema Nervioso Limitada
Bogotá
Site status: Not listed — confirm with the team
Psynapsis Salud Mental, S.A.
Risaralda
Site status: Not listed — confirm with the team
India · 14 sites
Vijayawada Institute of Mental Health and Neurosciences
Vijaywada, Andh Prad
Site status: Not listed — confirm with the team
Government Hospital for Mental Care
Visakhapatnam, Andh Prad
Site status: Not listed — confirm with the team
Hospital for Mental Health - Dept of Psychiatry
Ahmedabad, Gujarat
Site status: Not listed — confirm with the team
Sheth Vadilal Sarabhai General Hospital
Ahmedabad, Gujarat
Site status: Not listed — confirm with the team
SBKS Medical College and Brij Psychiatry Hospital
Vadodara, Gujarat
Site status: Not listed — confirm with the team
Victoria Hospital
Bangalore, Karna
Site status: Not listed — confirm with the team
Kasturba Medical College
Mangalore, Karna
Site status: Not listed — confirm with the team
Father Muller Institute of Medical Education and Research
Mangalore, Karna
Site status: Not listed — confirm with the team
Justice K.S. Hedge Charitable Hospital
Mangalore, Karna
Site status: Not listed — confirm with the team
Kasturba Hospital
Manipal, Karna
Site status: Not listed — confirm with the team
JSS Medical College and Hospital - Dept of Psychiatry
Mysore, Karna
Site status: Not listed — confirm with the team
Shanti Nursing Home
Aurangabad, Mahara
Site status: Not listed — confirm with the team
Deenanath Mangeshkar Hospital
Pune, Mahara
Site status: Not listed — confirm with the team
Madras Medical College & Government General Hospital
Chennai, Tamil Nadu
Site status: Not listed — confirm with the team
Lithuania · 4 sites
Ziegzdriai Mental Hospital, Public Institution
Kaunas
Site status: Not listed — confirm with the team
Klaipeda Mental Hospital, Public Institution
Klaipėda
Site status: Not listed — confirm with the team
Siauliai Mental Hospital, Public Institution
Šiauliai
Site status: Not listed — confirm with the team
Republican Vilnius Psychiatry Hospital, Public Institution
Vilnius
Site status: Not listed — confirm with the team
Philippines · 4 sites
Davao Medical School Foundation Hospital
Davao City
Site status: Not listed — confirm with the team
Makati Medical Center
Makati City
Site status: Not listed — confirm with the team
National Center for Mental Health
Mandaluyong
Site status: Not listed — confirm with the team
Metro Psych Facility
Mandaue City
Site status: Not listed — confirm with the team
United States · 25 sites
K&S Professional Research Services LLC
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Woodland International Research Group, LLC
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Clinical Pharmacological Studies, Inc.
Cerritos, California
Site status: Not listed — confirm with the team
Excell Research
Oceanside, California
Site status: Not listed — confirm with the team
University of California at Irvine Medical Center
Orange, California
Site status: Not listed — confirm with the team
California Clinical Trials
Paramount, California
Site status: Not listed — confirm with the team
CNRI - San Diego, LLC
San Diego, California
Site status: Not listed — confirm with the team
UCSD Medical Center
San Diego, California
Site status: Not listed — confirm with the team
Collaborative Neuroscience Network Inc.
Torrance, California
Site status: Not listed — confirm with the team
Florida Clinical Research Center, LLC
Fruitland Park, Florida
Site status: Not listed — confirm with the team
Segal Institute for Clinical Research
North Miami, Florida
Site status: Not listed — confirm with the team
Atlanta Center for Medical Research
Atlanta, Georgia
Site status: Not listed — confirm with the team
Uptown Research Institute, LLC
Chicago, Illinois
Site status: Not listed — confirm with the team
Alexian Brothers Health System
Hoffman Estates, Illinois
Site status: Not listed — confirm with the team
Lousiana Clinical Research, LLC
Shreveport, Louisiana
Site status: Not listed — confirm with the team
Precise Research Center
Flowood, Mississippi
Site status: Not listed — confirm with the team
St. Charles Psychiatric Associates-Midwest Research
Saint Charles, Missouri
Site status: Not listed — confirm with the team
St. Louis Clinical Trials
St Louis, Missouri
Site status: Not listed — confirm with the team
CRI Worldwide @ Lourdes
Willingboro, New Jersey
Site status: Not listed — confirm with the team
Neurobehavioral Research Inc.
Cedarhurst, New York
Site status: Not listed — confirm with the team
University of North Carolina at Chapel Hill
Raleigh, North Carolina
Site status: Not listed — confirm with the team
Keystone Clinical Studies, LLC
Norristown, Pennsylvania
Site status: Not listed — confirm with the team
Vanderbilt Heart and Vascular Institute
Nashville, Tennessee
Site status: Not listed — confirm with the team
Community Clinical Research, Inc.
Austin, Texas
Site status: Not listed — confirm with the team
Claghorn-Lesem Research Clinic, Inc.
Houston, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Lurasidone, Olanzapine, Placebo comparator, Lurasidone 40 mg tablets. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with schizophrenia; age range: From 18 Years to 75 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Sumitomo Pharma America, Inc., which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
